Clinical impact of medication adherence on 10‐year cardio‐cerebrovascular mortality in newly diagnosed hypertensive patients
The Journal of Clinical Hypertension Aug 17, 2021
Kim CL, Do YS, Kim BJ, et al. - A reduction in the rate of cardio-cerebrovascular (CCV) mortality can be achieved with high adherence to antihypertensive medication in newly diagnosed hypertensive patients.
Data from 20,836 patients with newly diagnosed hypertension were retrospectively reviewed.
Compliance ratio (CR) during the first year post-diagnosis of hypertension was assessed to determine medication adherence.
CCV mortality for 10 years was evaluated.
Significantly decreased risk of CCV death was observed in the CR ≥ 70% group vs in the CR < 70% group (hazard ratio, 0.70) for 10 years.
In patients with complications of hypertension, achievement of better long-term clinical results requires continued high adherence rate (CR ≥ 90).
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries